We used CYP2J2-transgenic mice to test the hypothesis that enhanced cardiac EET biosynthesis prevents arrhythmogenic substrate formation during the development of maladaptive cardiac hypertrophy. This evidence concerns the gene CYP2J2 and cardiac hypertrophy.